Droxia

Company
Bristol-Myers Squibb

Approval Status
Approved March 1998

Treatment for
sickle-cell anemia

Areas
Hematology

Droxia has been approved for people who have had three or more painful episodes with sickle-cell, which causes red blood cells to become oddly shaped and clump together. While taking the drug, patients must have a blood test every two weeks to ensure that their blood count is not depressed to a level at which they might be at risk for infection or bleeding.

Droxia Drug Information

The Droxia drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top